A

Arrowhead Pharmaceuticals
D

ARWR

20.510
USD
1.73
(9.21%)
مغلق
حجم التداول
151,310
الربح لكل سهم
-1
العائد الربحي
-
P/E
-17
حجم السوق
2,835,662,351
أصول ذات صلة
ALNY
ALNY
6.65
(1.50%)
449.19 USD
C
CRSP
0.853
(1.45%)
59.683 USD
E
EDIT
0.08000
(2.70%)
3.04000 USD
I
IONS
0.910
(2.12%)
43.780 USD
MRNA
MRNA
1.330
(4.98%)
28.020 USD
N
NTLA
0.090
(0.83%)
10.995 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
S
SGMO
0.02420
(4.37%)
0.57800 USD
S
SRPT
1.500
(7.39%)
21.810 USD
VRTX
VRTX
2.49
(0.64%)
392.97 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.